"The field has changed," notes Joel Gallant, M.D., M.P.H. "There are other things to learn about" besides the results of the latest randomized, controlled clinical trials. In this in-depth analysis, Gallant explains how some of CROI's key presentations may alter the way HIV clinicians approach antiretroviral therapy for their patients.